CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +6,250 | 6,250 | ||
| 2024-08-30 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2024-08-30 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2024-05-25 | Wasman Jane Director | Grant or award | +25,000 | 100,000 | ||
| 2024-05-25 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-25 | MOOS WALTER H Director | Grant or award | +25,000 | 102,222 | ||
| 2024-05-25 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-25 | LAPOINTE ANTHONY GREGG Director | Grant or award | +25,000 | 100,000 | ||
| 2024-05-25 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-25 | Kotzin Brian L. Director | Grant or award | +25,000 | 100,000 | ||
| 2024-05-25 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-25 | HANNAH ALISON L. Director | Grant or award | +25,000 | 81,250 | ||
| 2024-05-25 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-25 | Ali-Jackson Kamil Director | Grant or award | +25,000 | 68,750 | ||
| 2024-05-25 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-03-27 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +187,500 | 187,500 | ||
| 2024-02-28 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2024-02-28 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +78,500 | 78,500 | ||
| 2024-02-28 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2024-02-28 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +78,500 | 78,500 |
Page 7 of 9 · 176 trades